International Stem Cell Stock Current Liabilities
| ISCO Stock | USD 0.10 0.01 9.09% |
International Stem Cell fundamentals help investors to digest information that contributes to International Stem's financial success or failures. It also enables traders to predict the movement of International OTC Stock. The fundamental analysis module provides a way to measure International Stem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to International Stem otc stock.
International |
International Stem Cell OTC Stock Current Liabilities Analysis
International Stem's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current International Stem Current Liabilities | 5.54 M |
Most of International Stem's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, International Stem Cell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, International Stem Cell has a Current Liabilities of 5.54 M. This is 99.68% lower than that of the Biotechnology sector and 98.98% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.93% higher than that of the company.
International Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses International Stem's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of International Stem could also be used in its relative valuation, which is a method of valuing International Stem by comparing valuation metrics of similar companies.International Stem is currently under evaluation in current liabilities category among its peers.
International Fundamentals
| Return On Equity | -6.92 | |||
| Return On Asset | -0.0685 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 5.11 M | |||
| Shares Outstanding | 8 M | |||
| Shares Owned By Insiders | 53.77 % | |||
| Price To Earning | 103.12 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 7.18 M | |||
| Gross Profit | 4.24 M | |||
| EBITDA | (509 K) | |||
| Net Income | (899 K) | |||
| Cash And Equivalents | 586 K | |||
| Cash Per Share | 0.07 X | |||
| Total Debt | 4.31 M | |||
| Current Ratio | 0.64 X | |||
| Book Value Per Share | (0.58) X | |||
| Cash Flow From Operations | (1.3 M) | |||
| Earnings Per Share | (0.04) X | |||
| Target Price | 0.54 | |||
| Number Of Employees | 26 | |||
| Beta | 0.65 | |||
| Market Capitalization | 1.68 M | |||
| Total Asset | 4.95 M | |||
| Retained Earnings | (114.79 M) | |||
| Working Capital | (2.55 M) | |||
| Current Asset | 2.99 M | |||
| Current Liabilities | 5.54 M | |||
| Z Score | -31.2 | |||
| Net Asset | 4.95 M |
About International Stem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze International Stem Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of International Stem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of International Stem Cell based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with International Stem
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if International Stem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International Stem will appreciate offsetting losses from the drop in the long position's value.Moving against International OTC Stock
| 0.46 | BKRKY | Bank Rakyat Normal Trading | PairCorr |
| 0.44 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.41 | PPERY | Bank Mandiri Persero Normal Trading | PairCorr |
| 0.41 | PBCRY | Bank Central Asia | PairCorr |
| 0.41 | MEDS | Trxade Group Symbol Change | PairCorr |
The ability to find closely correlated positions to International Stem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace International Stem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back International Stem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling International Stem Cell to buy it.
The correlation of International Stem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as International Stem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if International Stem Cell moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for International Stem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in International OTC Stock
International Stem financial ratios help investors to determine whether International OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Stem security.